Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL
tel-00827710, version 1 - 29 May 2013 Figure 42. Inhibition of cross-presentation does not require cell-intrinsic production of type I IFN by cDCs. (A) WT, IRF3/7 DKO and (IRF3/7 DKO into WT) bone-marrow chimeras were injected with 100µg of poly I:C. At 2 and 6 hours post-stimulation, mice were bled to determine the plasma concentration of IFNα. (B) Mice were immunized i.d. with 5x10 5 K bm1 mOva splenocytes and received 100µg of poly I:C at 7 hours. Three days later, 5x10 6 CD45.1 + CFSE-labeled OT-I splenocytes were transferred i.v. The percentage of undivided OT-I was determined 3 days later and normalized for each mouse strain by comparing it with the percentage of undivided OT-I for the nonimmunized animals of the same background. NI, non-immunized mice. 3) Early poly I:C affects DC numbers and phenotype We demonstrated that the inhibition of cross-priming upon early delivery of poly I:C was type I IFN-dependent and characterized by an absence of cross-presenting DCs. To more precisely determine the action of poly I:C on host DCs, we performed an in vivo kinetic study, enumerating and phenotyping DC populations in the spleen and lymph nodes of WT mice. We focused on CD8α + DCs and CD103 + DCs, as these two subsets are known to respond to the TLR3 ligand poly I:C and are required for antigen cross-presentation (del Rio et al., 2007; 122
tel-00827710, version 1 - 29 May 2013 den Haan et al., 2000). Following poly I:C injection, we observed a striking decrease in the total number of splenic CD8α + DCs (Figure 43A). Analysis of the remaining cells indicated that activation markers CD86 and MHC-II are upregulated within 15h post-injection, indicating that maturation is a rapid process (Figure 43B). In contrast to the spleen, DC numbers in lymph nodes increased after poly I:C injection; and again the cells demonstrated a mature phenotype within 1 day of poly I:C administration (Figure 43B). Clearly, poly I:C impacted survival and/or migration of DCs in the lymphoid organs. This effect may be responsible for the inhibition of cross-priming if it results in the loss of DCs available at the site of injection, prepared to take up antigen. This rapid DC maturation could also contribute to the inhibition of subsequent priming by downregulating antigen engulfment, which is a characteristic feature of immature DCs. Page 123 of 256
- Page 71 and 72: tel-00827710, version 1 - 29 May 20
- Page 73 and 74: tel-00827710, version 1 - 29 May 20
- Page 75 and 76: tel-00827710, version 1 - 29 May 20
- Page 77 and 78: tel-00827710, version 1 - 29 May 20
- Page 79 and 80: tel-00827710, version 1 - 29 May 20
- Page 81 and 82: tel-00827710, version 1 - 29 May 20
- Page 83 and 84: tel-00827710, version 1 - 29 May 20
- Page 85 and 86: tel-00827710, version 1 - 29 May 20
- Page 87 and 88: tel-00827710, version 1 - 29 May 20
- Page 89 and 90: tel-00827710, version 1 - 29 May 20
- Page 91 and 92: tel-00827710, version 1 - 29 May 20
- Page 93 and 94: tel-00827710, version 1 - 29 May 20
- Page 95 and 96: tel-00827710, version 1 - 29 May 20
- Page 97 and 98: tel-00827710, version 1 - 29 May 20
- Page 99 and 100: tel-00827710, version 1 - 29 May 20
- Page 101 and 102: tel-00827710, version 1 - 29 May 20
- Page 103 and 104: tel-00827710, version 1 - 29 May 20
- Page 105 and 106: tel-00827710, version 1 - 29 May 20
- Page 107 and 108: tel-00827710, version 1 - 29 May 20
- Page 109 and 110: tel-00827710, version 1 - 29 May 20
- Page 111 and 112: tel-00827710, version 1 - 29 May 20
- Page 113 and 114: tel-00827710, version 1 - 29 May 20
- Page 115 and 116: tel-00827710, version 1 - 29 May 20
- Page 117 and 118: tel-00827710, version 1 - 29 May 20
- Page 119 and 120: tel-00827710, version 1 - 29 May 20
- Page 121: tel-00827710, version 1 - 29 May 20
- Page 125 and 126: tel-00827710, version 1 - 29 May 20
- Page 127 and 128: tel-00827710, version 1 - 29 May 20
- Page 129 and 130: tel-00827710, version 1 - 29 May 20
- Page 131 and 132: tel-00827710, version 1 - 29 May 20
- Page 133 and 134: tel-00827710, version 1 - 29 May 20
- Page 135 and 136: tel-00827710, version 1 - 29 May 20
- Page 137 and 138: tel-00827710, version 1 - 29 May 20
- Page 139 and 140: tel-00827710, version 1 - 29 May 20
- Page 141 and 142: tel-00827710, version 1 - 29 May 20
- Page 143 and 144: tel-00827710, version 1 - 29 May 20
- Page 145 and 146: tel-00827710, version 1 - 29 May 20
- Page 147 and 148: tel-00827710, version 1 - 29 May 20
- Page 149 and 150: tel-00827710, version 1 - 29 May 20
- Page 151 and 152: tel-00827710, version 1 - 29 May 20
- Page 153 and 154: tel-00827710, version 1 - 29 May 20
- Page 155 and 156: tel-00827710, version 1 - 29 May 20
- Page 157 and 158: tel-00827710, version 1 - 29 May 20
- Page 159 and 160: tel-00827710, version 1 - 29 May 20
- Page 161 and 162: tel-00827710, version 1 - 29 May 20
- Page 163 and 164: tel-00827710, version 1 - 29 May 20
- Page 165 and 166: tel-00827710, version 1 - 29 May 20
- Page 167 and 168: tel-00827710, version 1 - 29 May 20
- Page 169 and 170: tel-00827710, version 1 - 29 May 20
- Page 171 and 172: tel-00827710, version 1 - 29 May 20
tel-00827710, version 1 - 29 May 2013<br />
<strong>de</strong>n Haan <strong>et</strong> al., 2000). Following poly I:C injection, we observed a striking <strong>de</strong>crease in the<br />
total number of splenic CD8α + DCs (Figure 43A). Analysis of the remaining cells indicated<br />
that activation markers CD86 and MHC-II are upregulated within 15h post-injection,<br />
indicating that maturation is a rapid process (Figure 43B). In contrast to the spleen, DC<br />
numbers in lymph no<strong>de</strong>s increased after poly I:C injection; and again the cells <strong>de</strong>monstrated a<br />
mature phenotype within 1 day of poly I:C administration (Figure 43B). Clearly, poly I:C<br />
impacted survival and/or migration of DCs in the lymphoid organs. This effect may be<br />
responsible for the inhibition of cross-priming if it results in the loss of DCs available at the<br />
site of injection, prepared to take up antigen. This rapid DC maturation could also contribute<br />
to the inhibition of subsequent priming by downregulating antigen engulfment, which is a<br />
characteristic feature of immature DCs.<br />
Page 123 of 256